Search Result "BLyS"
A Comparison of Biological Activity of B Lymphocyte Stimulator (BLyS) Antagonist Peptibodies and the Elucidation of Possible BLyS Binding Sites
Journal: Protein & Peptide Letters
Volume: 23 Issue: 1 Year: 2016 Page: 17-23
Author(s): Xiafei Hao, Yanfeng Zhu, Chang Zheng, Xuegang Fu, Jiannan Feng, Beifen Shen, Jing Wei, Jian Sun
Targeting BLyS in Systemic Lupus Erythematosus
Journal: Recent Patents on Inflammation & Allergy Drug Discovery
Volume: 6 Issue: 2 Year: 2012 Page: 91-96
Author(s): Yaoyang Liu,Antonio La Cava
Exploring the Possible Prognostic Role of B-Lymphocyte Stimulator (BLyS) in a Large Series of Patients with Neuroendocrine Tumors
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 18 Issue: 0 Year: 2018 Page: 1-8
Author(s): Franco Grimaldi,Fabio Vescini,Veronica Tonelli,Cinzia Pistis,Elda Kara,Vincenzo Triggiani,Elio Tonutti,Francesco Curcio,Martina Fabris
The Role of B-Lymphocyte Stimulator in Neuroendocrine Tumors: Correlation with Tumor Differentiation, Disease status and the Presence of Metastases
Journal: Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry
Volume: 11 Issue: 4 Year: 2011 Page: 306-314
Author(s): Martina Fabris, Elio Tonutti, Carolina Panighel, Nadia Blasone, Daniela Visentini, Stefano Pizzolitto, Giovanna De Maglio, Miriam Isola, Francesco Curcio, Franco Grimaldi
Therapeutic Targeting of B Lymphocyte Stimulator (BLyS) in the Rheumatic Diseases
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 6 Issue: 4 Year: 2006 Page: 351-358
Author(s): William Stohl
BLyS: The Pivotal Determinant of Peripheral B Cell Selection and Lifespan
Journal: Current Pharmaceutical Design
Volume: 9 Issue: 2 Year: 2003 Page: 1833-1847
Author(s): Susan Harless Smith, Michael P. Cancro
A Review of Clinical Trials of Belimumab in the Management of Systemic Lupus Erythematosus
Journal: Current Pharmaceutical Design
Volume: 22 Issue: 41 Year: 2016 Page: 6306-6312
Author(s): Alexis Garcia,Juan B. De Sanctis
Can Drug Effects Help Elucidate the Pathogenesis of SLE?
Journal: Current Rheumatology Reviews
Volume: 2 Issue: 3 Year: 2006 Page: 233-244
Author(s): Celia J. Fang, Bevra H. Hahn, Daniel E. Furst
Cyclophosphamide: Time to Say Goodnight and Goodbye?
Journal: Current Rheumatology Reviews
Volume: 1 Issue: 2 Year: 2005 Page: 189-191
Author(s): Catherine Edwards, David Isenberg
Novel and Emerging Drugs for Systemic Lupus Erythematosus: Mechanism of Action and Therapeutic Activity
Journal: Current Medicinal Chemistry
Volume: 19 Issue: 3 Year: 2012 Page: 438-453
Author(s): E. Robak, T. Robak